Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma

Molecular Cancer Therapeutics
Yevgen ChornenkyyCynthia Hawkins

Abstract

Pediatric high-grade astrocytomas (pHGA) and diffuse intrinsic pontine gliomas (DIPG) are devastating malignancies for which no effective therapies exist. We investigated the therapeutic potential of PARP1 inhibition in preclinical models of pHGA and DIPG. PARP1 levels were characterized in pHGA and DIPG patient samples and tumor-derived cell lines. The effects of PARP inhibitors veliparib, olaparib, and niraparib as monotherapy or as radiosensitizers on cell viability, DNA damage, and PARP1 activity were evaluated in a panel of pHGA and DIPG cell lines. Survival benefit of niraparib was examined in an orthotopic xenograft model of pHGA. About 85% of pHGAs and 76% of DIPG tissue microarray samples expressed PARP1. Six of 8 primary cell lines highly expressed PARP1. Interestingly, across multiple cell lines, some PARP1 protein expression was required for response to PARP inhibition; however, there was no correlation between protein level or PARP1 activity and sensitivity to PARP inhibitors. Niraparib was the most effective at reducing cell viability and proliferation (MTT and Ki67). Niraparib induced DNA damage (γH2AX foci) and induced growth arrest. Pretreatment of pHGA cells with a sublethal dose of niraparib (1 μmol/L) before...Continue Reading

References

Jul 1, 1987·Neurologia Medico-chirurgica·I TakeshitaK Kitamura
Dec 17, 1994·BMJ : British Medical Journal·C A Stiller
Nov 6, 1998·Molecular Pharmacology·H HosoiP J Houghton
Sep 7, 1999·International Journal of Radiation Oncology, Biology, Physics·J GrillC Kalifa
Nov 7, 1999·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·C R Freeman, G Perilongo
Jul 3, 2004·The Lancet Oncology·Raymond K MulhernLarry E Kun
Mar 3, 2006·The Lancet Oncology·Darren HargraveEric Bouffet
Mar 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sarah S DonaldsonPaul Graham Fisher
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cherrie K DonawhoDavid J Frost
Dec 7, 2007·Biochemical and Biophysical Research Communications·Marc AudebertPatrick Calsou
Dec 24, 2008·The Journal of Cell Biology·Kazuto SugimuraKatsuzumi Okumura
Jun 18, 2009·Pediatric Blood & Cancer·Valerie N BartonNicholas K Foreman
Dec 5, 2009·Seminars in Radiation Oncology·Thomas E MerchantJay S Loeffler
Jan 30, 2010·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Gregory T Armstrong
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maryam ZarghooniCynthia Hawkins
Oct 23, 2010·Molecular Cell·Alberto Ciccia, Stephen J Elledge
Jan 7, 2011·The New England Journal of Medicine·Joyce O'ShaughnessyCharles Bradley
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Michelle MonjePhilip A Beachy
Mar 17, 2011·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Matthieu VinchonIsabelle Delestret
Aug 19, 2011·Neuro-oncology·Stuart J SmithUNKNOWN Children's Cancer and Leukaemia Group Biological Studies Committee
Nov 3, 2012·Cancer Research·Junko MuraiYves Pommier
Dec 28, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Khanh Do, Alice P Chen
Oct 1, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert J CardnellLauren A Byers
Dec 21, 2013·Molecular Cancer Therapeutics·Junko MuraiYves Pommier
Apr 8, 2014·Nature Genetics·Kathryn R TaylorJacques Grill

❮ Previous
Next ❯

Citations

May 19, 2019·Journal of Experimental & Clinical Cancer Research : CR·Ignacio Campillo-Marcos, Pedro A Lazo
Oct 28, 2019·Anti-cancer Agents in Medicinal Chemistry·Priyanka VermaIndrakant K Singh
Aug 10, 2017·Frontiers in Pharmacology·Wenyong LongQing Liu
Oct 4, 2020·Cancers·Henriette PedersenPetra Hamerlik
Apr 13, 2018·Current Treatment Options in Oncology·Alexandra S ZimmerJung-Min Lee
Jan 22, 2017·Cancer Research·Susanne KossatzThomas Reiner
Jan 12, 2021·Chinese Neurosurgical Journal·Dilakshan SrikanthanJames T Rutka
Mar 21, 2021·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Fabio AimiMichael O Hottiger
Nov 7, 2020·Drug Discovery Today·Samridhi Lal, Timothy J Snape
Apr 4, 2021·Cells·Ann-Katrin Hopp, Michael O Hottiger
Sep 28, 2017·Experimental Cell Research·Michaël H MeelEsther Hulleman
Apr 20, 2021·Frontiers in Oncology·Dennis S MetselaarEsther Hulleman
May 18, 2021·Frontiers in Molecular Biosciences·Jessica BuckRaelene Endersby
Sep 27, 2018·Molecular Pharmaceutics·Mark C de GooijerOlaf van Tellingen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.